1. Home
  2. BOLT vs SHFS Comparison

BOLT vs SHFS Comparison

Compare BOLT & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • SHFS
  • Stock Information
  • Founded
  • BOLT 2015
  • SHFS 2015
  • Country
  • BOLT United States
  • SHFS United States
  • Employees
  • BOLT N/A
  • SHFS N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • BOLT Health Care
  • SHFS Finance
  • Exchange
  • BOLT Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • BOLT 10.4M
  • SHFS 9.4M
  • IPO Year
  • BOLT 2021
  • SHFS N/A
  • Fundamental
  • Price
  • BOLT $6.17
  • SHFS $4.81
  • Analyst Decision
  • BOLT Buy
  • SHFS
  • Analyst Count
  • BOLT 3
  • SHFS 0
  • Target Price
  • BOLT $47.50
  • SHFS N/A
  • AVG Volume (30 Days)
  • BOLT 33.8K
  • SHFS 2.4M
  • Earning Date
  • BOLT 11-11-2025
  • SHFS 11-11-2025
  • Dividend Yield
  • BOLT N/A
  • SHFS N/A
  • EPS Growth
  • BOLT N/A
  • SHFS N/A
  • EPS
  • BOLT N/A
  • SHFS N/A
  • Revenue
  • BOLT $4,167,000.00
  • SHFS $11,720,493.00
  • Revenue This Year
  • BOLT N/A
  • SHFS N/A
  • Revenue Next Year
  • BOLT N/A
  • SHFS N/A
  • P/E Ratio
  • BOLT N/A
  • SHFS N/A
  • Revenue Growth
  • BOLT N/A
  • SHFS N/A
  • 52 Week Low
  • BOLT $4.59
  • SHFS $1.84
  • 52 Week High
  • BOLT $14.36
  • SHFS $10.78
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 63.23
  • SHFS 48.33
  • Support Level
  • BOLT $5.13
  • SHFS $6.70
  • Resistance Level
  • BOLT $6.20
  • SHFS $7.58
  • Average True Range (ATR)
  • BOLT 0.32
  • SHFS 0.81
  • MACD
  • BOLT 0.07
  • SHFS -0.01
  • Stochastic Oscillator
  • BOLT 87.19
  • SHFS 29.20

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: